+31.8%
CVS vs NDAQ
+52.5%
-20.7%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | NDAQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -0.9% | +0.1% | -0.6% |
| 7D | -1.9% | -1.6% | -0.3% | -1.6% |
| 30D | -0.3% | -1.5% | +1.2% | -0.1% |
| 3M | -1.1% | +8.0% | -9.2% | -2.7% |
| 6M | +23.7% | +7.7% | +16.0% | +21.7% |
| YTD | +23.0% | -2.3% | +25.3% | +23.0% |
| 1Y | +37.2% | +0.6% | +36.6% | +36.2% |
| 3Y | +62.4% | +90.9% | -28.5% | +36.4% |
| 5Y | +31.8% | +52.5% | -20.6% | +9.5% |
| All | +31.8% | +52.5% | -20.7% | +9.5% |
Cumulative growth
Daily Returns
Daily percentage return beside NDAQ.
Daily Out/Under-Performance
Portfolio return minus NDAQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NDAQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded NDAQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling